Sara Lemoinne

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

The hepatic portal area in homeostasis and disease.

The hepatic portal area in homeostasis and disease.

Journal: Clinical and molecular hepatology

Published: May 29, 2026

Benign Recurrent Intrahepatic Cholestasis in a Resource-Limited Setting: The First Reported Case From Cambodia.

Benign Recurrent Intrahepatic Cholestasis in a Resource-Limited Setting: The First Reported Case From Cambodia.

Journal: Clinics and research in hepatology and gastroenterology

Published: April 03, 2026

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.

Journal: Science advances

Published: December 17, 2025

Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.

Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.

Journal: Gastroenterology

Published: November 13, 2025

Mapping of class II HLA restriction of SepSecS-specific CD4 T-cell epitopes in autoimmune hepatitis.

Mapping of class II HLA restriction of SepSecS-specific CD4 T-cell epitopes in autoimmune hepatitis.

Journal: JHEP reports : innovation in hepatology

Published: September 22, 2025

Clec3b⁺ fibroblasts are the primary effectors of portal fibrosis following activation via a KLF4/periostin axis.

Clec3b⁺ fibroblasts are the primary effectors of portal fibrosis following activation via a KLF4/periostin axis.

Journal: Nature communications

Published: September 21, 2025

Features and Outcomes of 280 Patients With Idiosyncratic Drug-Induced Liver Injury: The REFHEPS Prospective Study.

Features and Outcomes of 280 Patients With Idiosyncratic Drug-Induced Liver Injury: The REFHEPS Prospective Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 04, 2025

ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators.

ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators.

Journal: Scientific reports

Published: May 13, 2025

A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reaction.

A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reaction.

Journal: JHEP reports : innovation in hepatology

Published: May 03, 2025

Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study.

Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study.

Journal: JHEP reports : innovation in hepatology

Published: April 20, 2025

Adipocyte-specific Mlkl knockout mitigates obesity-induced metabolic dysfunction by enhancing mitochondrial functions.

Adipocyte-specific Mlkl knockout mitigates obesity-induced metabolic dysfunction by enhancing mitochondrial functions.

Journal: Cell death & disease

Published: April 03, 2025

Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis.

Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis.

Journal: Journal of hepatology

Published: November 01, 2024

Showing 1-12 of 51

Last Updated: 09/26/2026